REVB
NASDAQ · Biotechnology
Revelation Biosciences Inc
$0.86
-0.01 (-1.25%)
Open$0.88
Previous Close$0.87
Day High$0.89
Day Low$0.83
52W High$6.76
52W Low$0.86
Volume—
Avg Volume29.7K
Market Cap3.47M
P/E Ratio—
EPS$-6.33
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,088.2% upside
Current
$0.86
$0.86
Target
$10.21
$10.21
$7.91
$10.21 avg
$15.75
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 725.2K | 710.5K | 685.3K |
| Net Income | -167,658 | -204,058 | -214,742 |
| Profit Margin | -23.1% | -28.7% | -31.3% |
| EBITDA | -214,609 | -243,655 | -229,479 |
| Free Cash Flow | -113,026 | -111,014 | -146,791 |
| Rev Growth | -8.8% | +0.9% | +1.6% |
| Debt/Equity | 0.76 | 0.62 | 0.70 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |